Unveiling the Complex Role of Exosomes in Alzheimer’s Disease
Open accessThe DOI matches its Crossref record; 249 of the 249 references it cites were found in a registry or an index.
Abstract
Alzheimer's disease (AD) is the most common neurodegenerative illness, characterized by memory loss and cognitive decline, accounting for 60-80% of dementia cases. AD is characterized by senile plaques made up of amyloid β (Aβ) protein, intracellular neurofibrillary tangles caused by hyperphosphorylation of tau protein linked with microtubules, and neuronal loss. Currently, therapeutic treatments and nanotechnological developments are effective in treating the symptoms of AD, but a cure for the illness has not yet been found. Recently, the increased study of extracellular vesicles (EVs) has led to a growing awareness of their significant involvement in neurodegenerative disorders, including AD. Exosomes are small extracellular vesicles that transport various components including messenger RNAs, non-coding RNAs, proteins, lipids, DNA, and other bioactive compounds from one cell to another, facilitating information transmission and material movement. There is growing evidence indicating that exosomes have complex functions in AD. Exosomes may have a dual role in Alzheimer's disease by contributing to neuronal death and also helping to alleviate the pathological progression of the disease. Therefore, the primary aim of this review is to outline the updated understandings on exosomes biogenesis and many functions of exosomes in the generation, conveyance, distribution, and elimination of hazardous proteins related to Alzheimer's disease. This review is intended to provide novel insights for understanding the development, specific treatment, and early detection of Alzheimer's disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“They seem to display a dual function in both expediting disease progression (e.g., triggering inflammation and oxidative stress) and slowing it down (Aβ and tau clearance) [111].”
From Advances in Strategies to Transport Nanoparticles Across the Blood–Brain Barrier for Drug Delivery into the Brain for the Treatment of Alzheimer’s Disease (2026) · cites this paper as [111]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Three main roles have been identified for exosomes: (i) to establish communication between cells and tissues by exchange of their intrinsic content; (ii) as diagnostic biomarkers; (iii) as DDS due to their properties (high stability, minimal immunogenicity, ease in crossing biological barriers, target specific cells or tissues, etc.) [111,112].”
From Advances in Strategies to Transport Nanoparticles Across the Blood–Brain Barrier for Drug Delivery into the Brain for the Treatment of Alzheimer’s Disease (2026) · cites this paper as [111]
The cited source says what the claim attributes to it.
In the citing paper
“Exosomes are extracellular vesicles with a diameter of around 30–150 nm, secreted by most cell types in the human body, and often found in physiological fluids such as blood, CSF, urine, and saliva [111,112].”
From Advances in Strategies to Transport Nanoparticles Across the Blood–Brain Barrier for Drug Delivery into the Brain for the Treatment of Alzheimer’s Disease (2026) · cites this paper as [111]
The cited source says what the claim attributes to it.
In the citing paper
“It has been demonstrated that exosomes are capable of transporting both pathogenic molecules (e.g., Aβ, tau) and therapeutic compounds.”
From Targeted Nanoparticles for Drug Delivery Across the Blood–Brain Barrier in Early and Late Stages of Alzheimer's Disease: A Review (2026) · cites this paper as [91]
The cited source says what the claim attributes to it.
In the citing paper
“Their role in AD is dual: although they contribute to the disease’s pathogenesis, they also assist in the clearance of toxic protein aggregates and modulate neuroinflammation [91, 92].”
From Targeted Nanoparticles for Drug Delivery Across the Blood–Brain Barrier in Early and Late Stages of Alzheimer's Disease: A Review (2026) · cites this paper as [91]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Théry, C., Witwer, K. W., Aikawa, E., Alcaraz, M. J., Anderson, J. D., Andriantsitohaina, R., Antoniou, A., Arab, T., Archer, F., Atkin‐Smith, G. K., et al. (2018) · Journal of Extracellular Vesicles · doi:10.1080/20013078.2018.1535750 · Cited by 11,099 · cited 1×
“38 The Biological Characteristics of Exosomes Exosomes were first reported in the early 1980s to analyse vesicles released by various cultured cells, with a size range of 40 to 1000 nm.”
BackgroundThe biology , function , and biomedical applications of exosomes
Kalluri, R., & LeBleu, V. S. (2020) · Science · doi:10.1126/science.aau6977 · Cited by 10,770 · cited 1×
“9 Exosomes in the central nervous system (CNS) transmit messages locally inside cells and extensively across the brain via the cerebrospinal fluid (CSF).”
BackgroundShedding light on the cell biology of extracellular vesicles
van Niel, G., D'Angelo, G., & Raposo, G. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.125 · Cited by 8,369
Extracellular vesicles: Exosomes, microvesicles, and friends
Raposo, G., & Stoorvogel, W. (2013) · Journal of Cell Biology · doi:10.1083/jcb.201211138 · Cited by 8,099
Biogenesis, Secretion, and Intercellular Interactions of Exosomes and Other Extracellular Vesicles
Colombo, M., Raposo, G., & Théry, C. (2014) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-101512-122326 · Cited by 6,186 · cited 1×
“39,40 Exosome membranes are mostly phospholipids and proteins, with flag molecules including CD9, CD63, CD81, CD82, adhesion proteins, integrins, and glycoproteins on the surface.”
BackgroundBiological properties of extracellular vesicles and their physiological functions
Yáñez‐Mó, M., Siljander, P. R. ‐., Andreu, Z., Bedina Zavec, A., Borràs, F. E., Buzas, E. I., Buzas, K., Casal, E., Cappello, F., Carvalho, J., et al. (2015) · Journal of Extracellular Vesicles · doi:10.3402/jev.v4.27066 · Cited by 5,926
Isolation and Characterization of Exosomes from Cell Culture Supernatants and Biological Fluids
Théry, C., Amigorena, S., Raposo, G., & Clayton, A. (2006) · Current Protocols in Cell Biology · doi:10.1002/0471143030.cb0322s30 · Cited by 5,766 · cited 1×
“36 A chemical conjugation approach may be used to modify the surface of paper in order to generate an immunoaffinity system that is based on paper.”
Method2016 Alzheimer's disease facts and figures
Alzheimer's Association (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.03.001 · Cited by 5,069
Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes
Alvarez-Erviti, L., Seow, Y., Yin, H., Betts, C., Lakhal, S., & Wood, M. J. A. (2011) · Nature Biotechnology · doi:10.1038/nbt.1807 · Cited by 4,930 · cited 3×
“214 Neuron-derived exosomes influence extracellular Aβ structure, resulting in non-toxic fibrils that promote microglia absorption.”
BackgroundMethodShankar, G. M., Li, S., Mehta, T. H., Garcia-Munoz, A., Shepardson, N. E., Smith, I., Brett, F. M., Farrell, M. A., Rowan, M. J., Lemere, C. A., et al. (2008) · Nature Medicine · doi:10.1038/nm1782 · Cited by 3,685
The neuropathological diagnosis of Alzheimer's disease
DeTure, M. A., & Dickson, D. W. (2019) · Molecular Neurodegeneration · doi:10.1186/s13024-019-0333-5 · Cited by 3,329
Current knowledge on exosome biogenesis and release
Hessvik, N. P., & Llorente, A. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2595-9 · Cited by 2,362
Huotari, J., & Helenius, A. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.286 · Cited by 2,265
Progress in Exosome Isolation Techniques
Li, P., Kaslan, M., Lee, S. H., Yao, J., & Gao, Z. (2017) · Theranostics · doi:10.7150/thno.18133 · Cited by 1,948 · cited 3×
“32,33 To separate exosomes according to their sizes, size-exclusion liquid chromatography (SEC) is useful.”
BackgroundTransmission and spreading of tauopathy in transgenic mouse brain
Clavaguera, F., Bolmont, T., Crowther, R. A., Abramowski, D., Frank, S., Probst, A., Fraser, G., Stalder, A. K., Beibel, M., Staufenbiel, M., et al. (2009) · Nature Cell Biology · doi:10.1038/ncb1901 · Cited by 1,803
Optimized exosome isolation protocol for cell culture supernatant and human plasma
Lobb, R. J., Becker, M., Wen Wen, S., Wong, C. S. F., Wiegmans, A. P., Leimgruber, A., & Möller, A. (2015) · Journal of Extracellular Vesicles · doi:10.3402/jev.v4.27031 · Cited by 1,705 · cited 1×
“32,33 To separate exosomes according to their sizes, size-exclusion liquid chromatography (SEC) is useful.”
BackgroundDepletion of microglia and inhibition of exosome synthesis halt tau propagation
Asai, H., Ikezu, S., Tsunoda, S., Medalla, M., Luebke, J., Haydar, T., Wolozin, B., Butovsky, O., Kügler, S., & Ikezu, T. (2015) · Nature Neuroscience · doi:10.1038/nn.4132 · Cited by 1,591 · cited 1×
“74 Glial cell-derived exosomes have the potential to promote Aβ aggregation in the brains of 5XFAD mice, along with spreading tau.”
BackgroundA review on Alzheimer's disease pathophysiology and its management: an update
Kumar, A., Singh, A., & Ekavali (2015) · Pharmacological Reports · doi:10.1016/j.pharep.2014.09.004 · Cited by 1,578
Zhuang, X., Xiang, X., Grizzle, W., Sun, D., Zhang, S., Axtell, R. C., Ju, S., Mu, J., Zhang, L., Steinman, L., et al. (2011) · Molecular Therapy · doi:10.1038/mt.2011.164 · Cited by 1,356
Ha, D., Yang, N., & Nadithe, V. (2016) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2016.02.001 · Cited by 1,346
Alzheimer’s disease β-amyloid peptides are released in association with exosomes
Rajendran, L., Honsho, M., Zahn, T. R., Keller, P., Geiger, K. D., Verkade, P., & Simons, K. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603838103 · Cited by 1,343 · cited 2×
“16 Vingtdeux et al found that MVBs are necessary for APP metabolism and can secrete all APP metabolites.”
Background(1987) · PubMed · Cited by 1,147
Arslan, F., Lai, R. C., Smeets, M. B., Akeroyd, L., Choo, A., Aguor, E. N. E., Timmers, L., van Rijen, H. V., Doevendans, P. A., Pasterkamp, G., et al. (2013) · Stem Cell Research · doi:10.1016/j.scr.2013.01.002 · Cited by 1,107 · cited 1×
“112 In addition, exosomes obtained from cells exposed to oxidative stress exhibited a reduction in the levels of proteins that promote cell survival and an increase in proteins that induce cell death.”
BackgroundBiomarkers for Alzheimer's disease: current status and prospects for the future
Blennow, K., & Zetterberg, H. (2018) · Journal of Internal Medicine · doi:10.1111/joim.12816 · Cited by 1,000 · cited 1×
“144 Aβ1−42, total tau (T-tau), and p-tau protein levels in cerebrospinal fluid (CSF) are the most commonly acknowledged AD biomarkers.”
BackgroundReddy, P. H., & Beal, M. F. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.12.002 · Cited by 975 · cited 1×
“107 Also, oxidative stress might alter the process of biogenesis, the release, and the composition of exosomes.”
BackgroundFiandaca, M. S., Kapogiannis, D., Mapstone, M., Boxer, A., Eitan, E., Schwartz, J. B., Abner, E. L., Petersen, R. C., Federoff, H. J., Miller, B. L., et al. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.06.008 · Cited by 959 · cited 1×
“51,165 It is worth noting that new studies have shown that the AD group had greater levels of neuron-derived exosomal Aβ1−42, T-tau, and p-T181-tau, which coincided with the levels in CSF.”
Cogswell, J. P., Ward, J., Taylor, I. A., Waters, M., Shi, Y., Cannon, B., Kelnar, K., Kemppainen, J., Brown, D., Chen, C., et al. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-14103 · Cited by 943
Bovine milk-derived exosomes for drug delivery
Munagala, R., Aqil, F., Jeyabalan, J., & Gupta, R. C. (2016) · Cancer Letters · doi:10.1016/j.canlet.2015.10.020 · Cited by 931 · cited 1×
“31 Since it is both simple and inexpensive, ultracentrifugation (UC) has become the method of choice for separating and purifying exosomes and particles that resemble them.”
MethodOxidative stress, mitochondrial dysfunction and neurodegenerative diseases; a mechanistic insight
Bhat, A. H., Dar, K. B., Anees, S., Zargar, M. A., Masood, A., Sofi, M. A., & Ganie, S. A. (2015) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2015.07.025 · Cited by 928 · cited 1×
“105 Metal ion-chelated Amyloid β may regenerate O2 by a three-step process including reduction to superoxide and oxygen peroxide, generation of OH radical, and the release of reactive oxygen species as byproducts.”
BackgroundOxidative Stress in Human Pathology and Aging: Molecular Mechanisms and Perspectives
Hajam, Y. A., Rani, R., Ganie, S. Y., Sheikh, T. A., Javaid, D., Qadri, S. S., Pramodh, S., Alsulimani, A., Alkhanani, M. F., Harakeh, S., et al. (2022) · Cells · doi:10.3390/cells11030552 · Cited by 915 · cited 1×
“101 To promote cell development and govern metabolism, the reactive oxygen species level must maintain signalling pathways such the Ras/AMPK, and Protein kinase-C pathways.”
BackgroundTapiola, T., Alafuzoff, I., Herukka, S.-K., Parkkinen, L., Hartikainen, P., Soininen, H., & Pirttilä, T. (2009) · Archives of Neurology · doi:10.1001/archneurol.2008.596 · Cited by 896 · cited 1×
“145,146 Even in the early to mid-stages of AD, these biomarkers could provide diagnostically useful information.”
BackgroundNeurovascular mechanisms and blood–brain barrier disorder in Alzheimer’s disease
Bell, R. D., & Zlokovic, B. V. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0522-3 · Cited by 860 · cited 1×
“126 The high incidence of vascular problems in AD, Aβ’s regulation of endothelial inflammation, and the close link between capillaries and amyloid-β deposits lead to cerebral vasculature involvement.”
BackgroundAn unconventional role for miRNA: let-7 activates toll-like receptor 7 and causes neurodegeneration
Lehmann, S. M., Krüger, C., Park, B., Derkow, K., Rosenberger, K., Baumgart, J., Trimbuch, T., Eom, G., Hinz, M., Kaul, D., et al. (2012) · Nature Neuroscience · doi:10.1038/nn.3113 · Cited by 786
(2019) · Handbook of Clinical Neurology · doi:10.1016/b978-0-12-804766-8.00013-3 · Cited by 783
Molecular mechanisms of neurodegeneration in Alzheimer's disease
Crews, L., & Masliah, E. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq160 · Cited by 772
Takahashi, R. H., Milner, T. A., Li, F., Nam, E. E., Edgar, M. A., Yamaguchi, H., Beal, M. F., Xu, H., Greengard, P., & Gouras, G. K. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64463-x · Cited by 706 · cited 1×
“13 Exosomes associated with AD were first discovered while studying the buildup of APP cleavage in MVBs, 14,15 which are considered as progenitors of exosomes.”
BackgroundNF-κB functions in synaptic signaling and behavior
Meffert, M. K., Chang, J. M., Wiltgen, B. J., Fanselow, M. S., & Baltimore, D. (2003) · Nature Neuroscience · doi:10.1038/nn1110 · Cited by 690
The release and trans-synaptic transmission of Tau via exosomes
Wang, Y., Balaji, V., Kaniyappan, S., Krüger, L., Irsen, S., Tepper, K., Chandupatla, R., Maetzler, W., Schneider, A., Mandelkow, E., et al. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0143-y · Cited by 674 · cited 1×
“49,50,71 Release of tau-containing exosomes is another way in which microglia aid in the spread of tau.”
BackgroundZhou, Y., Xu, H., Xu, W., Wang, B., Wu, H., Tao, Y., Zhang, B., Wang, M., Mao, F., Yan, Y., et al. (2013) · Stem Cell Research & Therapy · doi:10.1186/scrt194 · Cited by 644
Protein transmission in neurodegenerative disease
Peng, C., Trojanowski, J. Q., & Lee, V. M.-Y. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-020-0333-7 · Cited by 625 · cited 1×
“137 Reducing microglia numbers and blocking exosomal secretory routes decreases tau growth in both in vivo and in vitro experiments.”
BackgroundSphingolipid-modulated Exosome Secretion Promotes Clearance of Amyloid-β by Microglia
Yuyama, K., Sun, H., Mitsutake, S., & Igarashi, Y. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.324616 · Cited by 595 · cited 3×
“19 On the outer layer of exosomal membranes, glycochain membrane lipids (GSLs) expose their glycans to the environment.”
BackgroundInfluentialMicroglia, neuroinflammation, and beta-amyloid protein in Alzheimer’s disease
Cai, Z., Hussain, M. D., & Yan, L.-J. (2014) · International Journal of Neuroscience · doi:10.3109/00207454.2013.833510 · Cited by 583 · cited 1×
“103 Numerous studies show that neuroinflammation-induced oxidative stress increases Aβ production by increasing β and γ-secretase activity.”
BackgroundBobrie, A., Colombo, M., Krumeich, S., Raposo, G., & Théry, C. (2012) · Journal of Extracellular Vesicles · doi:10.3402/jev.v1i0.18397 · Cited by 579 · cited 1×
“39,40 Exosome membranes are mostly phospholipids and proteins, with flag molecules including CD9, CD63, CD81, CD82, adhesion proteins, integrins, and glycoproteins on the surface.”
BackgroundHuman adipose tissue-derived mesenchymal stem cells secrete functional neprilysin-bound exosomes
Katsuda, T., Tsuchiya, R., Kosaka, N., Yoshioka, Y., Takagaki, K., Oki, K., Takeshita, F., Sakai, Y., Kuroda, M., & Ochiya, T. (2013) · Scientific Reports · doi:10.1038/srep01197 · Cited by 565 · cited 1×
“216,217 In AD, stem cells and other cell-derived or bioengineered exosomes are useful.”
BackgroundAmyloid-Beta: A Crucial Factor in Alzheimer's Disease
Sadigh-Eteghad, S., Sabermarouf, B., Majdi, A., Talebi, M., Farhoudi, M., & Mahmoudi, J. (2015) · Medical Principles and Practice · doi:10.1159/000369101 · Cited by 537
Alzheimer’s disease pathology propagation by exosomes containing toxic amyloid-beta oligomers
Sardar Sinha, M., Ansell-Schultz, A., Civitelli, L., Hildesjö, C., Larsson, M., Lannfelt, L., Ingelsson, M., & Hallbeck, M. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1868-1 · Cited by 527 · cited 2×
“18 These evidences suggest that exosomes have a role in the dissemination of tau and Aβ, which in turn leads to pathological damage in AD, when considered collectively.”
BackgroundA blood based 12-miRNA signature of Alzheimer disease patients
Leidinger, P., Backes, C., Deutscher, S., Schmitt, K., Mueller, S. C., Frese, K., Haas, J., Ruprecht, K., Paul, F., Stähler, C., et al. (2013) · Genome Biology · doi:10.1186/gb-2013-14-7-r78 · Cited by 502
Cerebrospinal fluid protein biomarkers for Alzheimer’s disease
Blennow, K. (2004) · NeuroRX · doi:10.1602/neurorx.1.2.213 · Cited by 477 · cited 1×
“145,146 Even in the early to mid-stages of AD, these biomarkers could provide diagnostically useful information.”
BackgroundFader, C. M., Sánchez, D., Furlán, M., & Colombo, M. I. (2008) · Traffic · doi:10.1111/j.1600-0854.2007.00677.x · Cited by 470 · cited 1×
“117 118–121 Furthermore, the presence of nanoparticles, mechanical damage, or chemicals has been shown to cause oxidative stress, leading to an increase in the quantity of exosomes, which may also be accompanied by morphological alterations.”
BackgroundApoptotic Bodies: Particular Extracellular Vesicles Involved in Intercellular Communication
Battistelli, M., & Falcieri, E. (2020) · Biology · doi:10.3390/biology9010021 · Cited by 457
Extracellular vesicles in neurodegenerative disease — pathogenesis to biomarkers
Thompson, A. G., Gray, E., Heman-Ackah, S. M., Mäger, I., Talbot, K., Andaloussi, S. E., Wood, M. J., & Turner, M. R. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.68 · Cited by 431
Neuronal Exosomal miRNA-dependent Translational Regulation of Astroglial Glutamate Transporter GLT1
Morel, L., Regan, M., Higashimori, H., Ng, S. K., Esau, C., Vidensky, S., Rothstein, J., & Yang, Y. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.410944 · Cited by 430 · cited 1×
“241,242 Toxic Waste Scavenging and Neuroprotective Effects Exosomes have the ability to attach to Aβ via glycosphingolipids on the surface of the cell membrane, making them excellent Aβ scavengers.”
BackgroundInflammatory process in Alzheimer's Disease
Meraz-Ríos, M. A., Toral-Rios, D., Franco-Bocanegra, D., Villeda-Hernández, J., & Campos-Peña, V. (2013) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2013.00059 · Cited by 427
Central role for PICALM in amyloid-β blood-brain barrier transcytosis and clearance
Zhao, Z., Sagare, A. P., Ma, Q., Halliday, M. R., Kong, P., Kisler, K., Winkler, E. A., Ramanathan, A., Kanekiyo, T., Bu, G., et al. (2015) · Nature Neuroscience · doi:10.1038/nn.4025 · Cited by 410
Cheng, L., Doecke, J. D., Sharples, R. A., Villemagne, V. L., Fowler, C. J., Rembach, A., Martins, R. N., Rowe, C. C., Macaulay, S. L., Masters, C. L., et al. (2015) · Molecular Psychiatry · doi:10.1038/mp.2014.127 · Cited by 409
Lugli, G., Cohen, A. M., Bennett, D. A., Shah, R. C., Fields, C. J., Hernandez, A. G., & Smalheiser, N. R. (2015) · PLOS ONE · doi:10.1371/journal.pone.0139233 · Cited by 391
Exosomal cargo-loading and synthetic exosome-mimics as potential therapeutic tools
Li, S.-P., Lin, Z.-X., Jiang, X.-Y., & Yu, X.-Y. (2018) · Acta Pharmacologica Sinica · doi:10.1038/aps.2017.178 · Cited by 390 · cited 1×
“237 It’s possible that exosomes serve many purposes in the therapy of AD.”
BackgroundHuang, S., Ge, X., Yu, J., Han, Z., Yin, Z., Li, Y., Chen, F., Wang, H., Zhang, J., & Lei, P. (2018) · The FASEB Journal · doi:10.1096/fj.201700673r · Cited by 388 · cited 1×
“99 Overall, exosomes may enhance or inhibit the inflammatory response depending on the stimuli and cell types that create them.”
BackgroundCui, G., Wu, J., Mou, F., Xie, W., Wang, F., Wang, Q., Fang, J., Xu, Y., Dong, Y., Liu, J., et al. (2018) · The FASEB Journal · doi:10.1096/fj.201700600r · Cited by 387 · cited 2×
“244 Research has shown that glial cell control and reduction of inflammatory mediator levels controlling NF-kB pathways may be achieved with treatment with exosomes produced from MSCs. 245 Additionally, Past research has shown that when microglia consume exosomes, they may be able to lower brain Aβ-protein levels.”
BackgroundPerez-Gonzalez, R., Gauthier, S. A., Kumar, A., & Levy, E. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.404467 · Cited by 385 · cited 1×
“17,18 Additionally, exosomes can promote Aβ clearance, transporting Aβ to microglia’s lysosomes and degrading in them.”
BackgroundPerets, N., Betzer, O., Shapira, R., Brenstein, S., Angel, A., Sadan, T., Ashery, U., Popovtzer, R., & Offen, D. (2019) · Nano Letters · doi:10.1021/acs.nanolett.8b04148 · Cited by 382 · cited 1×
“247,248 Further research shows that MSC-derived exosomes may help enhance AD pathology and cognition.”
BackgroundCirculating miRNA Biomarkers for Alzheimer's Disease
Kumar, P., Dezso, Z., MacKenzie, C., Oestreicher, J., Agoulnik, S., Byrne, M., Bernier, F., Yanagimachi, M., Aoshima, K., & Oda, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069807 · Cited by 381 · cited 1×
“[192] miR-34c Plasma Upregulated The level of these miRNA in the serum of AD individuals can distinguish AD patients from healthy controls.”
BackgroundWinston, C. N., Goetzl, E. J., Akers, J. C., Carter, B. S., Rockenstein, E. M., Galasko, D., Masliah, E., & Rissman, R. A. (2016) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1016/j.dadm.2016.04.001 · Cited by 379
Jia, L., Qiu, Q., Zhang, H., Chu, L., Du, Y., Zhang, J., Zhou, C., Liang, F., Shi, S., Wang, S., et al. (2019) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2019.05.002 · Cited by 373 · cited 4×
“They found a correlation between the levels of exosomal biomarkers and those in CSF. Adverse events were recognized five to seven years before to cognitive impairment by combining exosomal biomarkers.”
MethodInfluentialHigh complement levels in astrocyte‐derived exosomes of Alzheimer disease
Goetzl, E. J., Schwartz, J. B., Abner, E. L., Jicha, G. A., & Kapogiannis, D. (2018) · Annals of Neurology · doi:10.1002/ana.25172 · Cited by 370 · cited 3×
“80 Patients in the CE 2 stage had lower levels of regulatory proteins and greater levels of complement proteins compared to those in the CE 1 preclinical stage, adding to the mounting evidence linking inflammatory chemicals in exosomes to AD by showing that levels of complement proteins in exosomes…”
BackgroundDeveloping and adopting safe and effective digital biomarkers to improve patient outcomes
Coravos, A., Khozin, S., & Mandl, K. D. (2019) · npj Digital Medicine · doi:10.1038/s41746-019-0090-4 · Cited by 361
Hedlund, M., Nagaeva, O., Kargl, D., Baranov, V., & Mincheva-Nilsson, L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016899 · Cited by 360
Wang, G., Dinkins, M., He, Q., Zhu, G., Poirier, C., Campbell, A., Mayer-Proschel, M., & Bieberich, E. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.340513 · Cited by 356 · cited 1×
“84 Both serum and brain tissue from 5XFAD mice and Alzheimer’s patients contain ceramide-enriched and astrocyte-derived exosomes connected to Aβ pathology.”
BackgroundChallenges in Clinical Development of Mesenchymal Stromal/Stem Cells: Concise Review
Mastrolia, I., Foppiani, E. M., Murgia, A., Candini, O., Samarelli, A. V., Grisendi, G., Veronesi, E., Horwitz, E. M., & Dominici, M. (2019) · Stem Cells Translational Medicine · doi:10.1002/sctm.19-0044 · Cited by 350 · cited 1×
“247,248 Further research shows that MSC-derived exosomes may help enhance AD pathology and cognition.”
BackgroundCui, G.-H., Guo, H.-D., Li, H., Zhai, Y., Gong, Z.-B., Wu, J., Liu, J.-S., Dong, Y.-R., Hou, S.-X., & Liu, J.-R. (2019) · Immunity & Ageing · doi:10.1186/s12979-019-0150-2 · Cited by 347
Yuyama, K., Sun, H., Sakai, S., Mitsutake, S., Okada, M., Tahara, H., Furukawa, J.-I., Fujitani, N., Shinohara, Y., & Igarashi, Y. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.577213 · Cited by 333 · cited 1×
“[232] Neuronal APP transgenic mice Reduce amyloid deposition and A β .”
BackgroundExosomes as mediators of neuroinflammation
Gupta, A., & Pulliam, L. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-68 · Cited by 328 · cited 1×
“95 MicroRNAs, an essential exosome cargo, also induce neuroinflammation.”
BackgroundThe Psychiatric Symptoms of Alzheimer's Disease
Merriam, A. E., Aronson, M. K., Gaston, P., Wey, S., & Katz, I. (1988) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1988.tb03427.x · Cited by 319
Prada, I., Gabrielli, M., Turola, E., Iorio, A., D’Arrigo, G., Parolisi, R., De Luca, M., Pacifici, M., Bastoni, M., Lombardi, M., et al. (2018) · Acta Neuropathologica · doi:10.1007/s00401-017-1803-x · Cited by 312 · cited 1×
“83 Aβ treatment in astrocytes leads to the production of the proapoptotic PAR-4 protein, leading to increased cell death in cultured astrocytes.”
BackgroundExosome-like Nanoparticles from Ginger Rhizomes Inhibited NLRP3 Inflammasome Activation
Chen, X., Zhou, Y., & Yu, J. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.9b00246 · Cited by 311 · cited 1×
“98 Microglia exosomes may sometimes decrease inflammation.”
The role of astrocytes in oxidative stress of central nervous system: A mixed blessing
Chen, Y., Qin, C., Huang, J., Tang, X., Liu, C., Huang, K., Xu, J., Guo, G., Tong, A., & Zhou, L. (2020) · Cell Proliferation · doi:10.1111/cpr.12781 · Cited by 307 · cited 1×
“123,124 Research indicates that microglia-produced inflammatory cytokines, regulated by Amyloid-β protein, accelerate AD development.”
BackgroundExosomes/miRNAs as mediating cell-based therapy of stroke
Xin, H., Li, Y., & Chopp, M. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00377 · Cited by 297 · cited 1×
“75,238 Previous research has effectively reduced total Aβ1−42 levels, a key component of the amyloid plaque in AD pathogenesis, by engineering exosomes laden with siRNAs to target central nervous system cells and suppress BACE1 expression.”
BackgroundLiu, S., Fan, M., Xu, J.-X., Yang, L.-J., Qi, C.-C., Xia, Q.-R., & Ge, J.-F. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02393-2 · Cited by 296 · cited 1×
“224 Furthermore, bone-MSC injection in double transgenic APP/PS1 mice may activate the sphingosine kinase-1/sphingosine-1-phosphate signaling pathway, reducing Aβ accumulation and promoting cognitive performance in AD animals.”
BackgroundExosomes in the Pathology of Neurodegenerative Diseases
Howitt, J., & Hill, A. F. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.r116.757955 · Cited by 288
Oxidative stress and β-amyloid protein in Alzheimer’s disease
Cai, Z., Zhao, B., & Ratka, A. (2011) · NeuroMolecular Medicine · doi:10.1007/s12017-011-8155-9 · Cited by 279
Ding, M., Shen, Y., Wang, P., Xie, Z., Xu, S., Zhu, Z., Wang, Y., Lyu, Y., Wang, D., Xu, L., et al. (2018) · Neurochemical Research · doi:10.1007/s11064-018-2641-5 · Cited by 276 · cited 1×
“228 Transfer of ADSCs-derived exosomes into N2a cells reduces intracellular Aβ levels.”
BackgroundPolanco, J. C., Scicluna, B. J., Hill, A. F., & Götz, J. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.709485 · Cited by 272 · cited 1×
“49,50,71 Release of tau-containing exosomes is another way in which microglia aid in the spread of tau.”
BackgroundPIKfyve inhibition increases exosome release and induces secretory autophagy
Hessvik, N. P., Øverbye, A., Brech, A., Torgersen, M. L., Jakobsen, I. S., Sandvig, K., & Llorente, A. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2309-8 · Cited by 269 · cited 1×
“115,116 Conversely, inhibiting autophagic trafficking facilitates exosome secretion.”
BackgroundLi, S., & Selkoe, D. J. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15007 · Cited by 263 · cited 1×
“125 Angiopathy in cardiovascular illnesses and AD is linked to amyloid, resulting in altered artery walls and increased microcapillary thickness in Aβ deposits.”
A potential function for neuronal exosomes: Sequestering intracerebral amyloid‐β peptide
Yuyama, K., Sun, H., Usuki, S., Sakai, S., Hanamatsu, H., Mioka, T., Kimura, N., Okada, M., Tahara, H., Furukawa, J.-I., et al. (2015) · FEBS Letters · doi:10.1016/j.febslet.2014.11.027 · Cited by 262 · cited 1×
“[233] Dendritic cells C57BL/6 mice Reduce A β and BACE1.”
BackgroundMicroRNAs in Plasma and Cerebrospinal Fluid as Potential Markers for Alzheimer's Disease
Kiko, T., Nakagawa, K., Tsuduki, T., Furukawa, K., Arai, H., & Miyazawa, T. (2014) · Journal of Alzheimer's Disease · doi:10.3233/jad-130932 · Cited by 256 · cited 1×
“[196] miR-384 Plasma Downregulated The level of this miRNA in the plasma of AD individuals can distinguish AD patients from healthy controls.”
BackgroundReza-Zaldivar, E. E., Hernández-Sapiéns, M. A., Gutiérrez-Mercado, Y. K., Sandoval-Ávila, S., Gomez-Pinedo, U., Márquez-Aguirre, A. L., Vázquez-Méndez, E., Padilla-Camberos, E., & Canales-Aguirre, A. A. (2019) · Neural Regeneration Research · doi:10.4103/1673-5374.255978 · Cited by 256
Sharples, R. A., Vella, L. J., Nisbet, R. M., Naylor, R., Perez, K., Barnham, K. J., Masters, C. L., & Hill, A. F. (2008) · The FASEB Journal · doi:10.1096/fj.07-9357com · Cited by 254
Endocytic pathways and endosomal trafficking: a primer
Elkin, S. R., Lakoduk, A. M., & Schmid, S. L. (2016) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-016-0432-7 · Cited by 254
Circulating microRNAs as potential biomarkers for psychiatric and neurodegenerative disorders
van den Berg, M. M. J., Krauskopf, J., Ramaekers, J. G., Kleinjans, J. C. S., Prickaerts, J., & Briedé, J. J. (2020) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2019.101732 · Cited by 253 · cited 1×
“159 The AD patients had significantly lower levels of these four miRNAs than the controls.”
BackgroundBlood neuro‐exosomal synaptic proteins predict Alzheimer's disease at the asymptomatic stage
Jia, L., Zhu, M., Kong, C., Pang, Y., Zhang, H., Qiu, Q., Wei, C., Tang, Y., Wang, Q., Li, Y., et al. (2021) · Alzheimer's & Dementia · doi:10.1002/alz.12166 · Cited by 250 · cited 3×
“These findings indicate that alterations in Ng may be indicative of the progressive breakdown of synaptic connections, which is associated with cognitive impairments in AD and FTD. Crucially, alterations in the levels of synaptic protein, neurogranin (Ng) and MFN-2, LAMP2, and golgin A4 from neuronal exosomes are help…”
BackgroundPathogenesis of synaptic degeneration in Alzheimer's disease and Lewy body disease
Overk, C. R., & Masliah, E. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.01.015 · Cited by 242 · cited 1×
“81,82 A study found that EV produced by Aβ1−42 activates microglia, which in turn causes a significant reduction in the density of dendritic spines in hippocampal neurons both in living organisms and in laboratory settings.”
BackgroundChiaradia, E., Tancini, B., Emiliani, C., Delo, F., Pellegrino, R. M., Tognoloni, A., Urbanelli, L., & Buratta, S. (2021) · Cells · doi:10.3390/cells10071763 · Cited by 241 · cited 2×
“121 Regionally raised capillary concentration, vascular loop growth, glomeruloid vascular structure creation, and VEGF and TNF release are biochemical and morphological signs of angiogenesis.”
BackgroundA Seed for Alzheimer Amyloid in the Brain
Hayashi, H., Kimura, N., Yamaguchi, H., Hasegawa, K., Yokoseki, T., Shibata, M., Yamamoto, N., Michikawa, M., Yoshikawa, Y., Terao, K., et al. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.0861-04.2004 · Cited by 239 · cited 1×
“62,63 Especially NDE exosomes enrich GSLs. Exosomes may serve seeds for Aβ aggregation, and plaque development.”
BackgroundQi, Y., Guo, L., Jiang, Y., Shi, Y., Sui, H., & Zhao, L. (2020) · Drug Delivery · doi:10.1080/10717544.2020.1762262 · Cited by 239 · cited 1×
“214 To boost Que bioavailability and brain targeting and potently enhance cognitive performance, Qi et al 239 produced exosomes loaded with Que (EXO-Que).”
MethodMicroRNA Profiling of CSF Reveals Potential Biomarkers to Detect Alzheimer`s Disease
Denk, J., Boelmans, K., Siegismund, C., Lassner, D., Arlt, S., & Jahn, H. (2015) · PLOS ONE · doi:10.1371/journal.pone.0126423 · Cited by 236
Atienzar‐Aroca, S., Flores‐Bellver, M., Serrano‐Heras, G., Martinez‐Gil, N., Barcia, J. M., Aparicio, S., Perez‐Cremades, D., Garcia‐Verdugo, J. M., Diaz‐Llopis, M., Romero, F. J., et al. (2016) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12834 · Cited by 231
Vella, L., Hill, A., & Cheng, L. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17020173 · Cited by 230
Exosomes and other extracellular vesicles in neural cells and neurodegenerative diseases
Janas, A. M., Sapoń, K., Janas, T., Stowell, M. H. B., & Janas, T. (2016) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2016.02.011 · Cited by 225
Biomarkers for the Early Detection and Progression of Alzheimer's Disease
Counts, S. E., Ikonomovic, M. D., Mercado, N., Vega, I. E., & Mufson, E. J. (2017) · Neurotherapeutics · doi:10.1007/s13311-016-0481-z · Cited by 224
Advances in exosomes technology
Chen, B.-Y., Sung, C. W.-H., Chen, C., Cheng, C.-M., Lin, D. P.-C., Huang, C.-T., & Hsu, M.-Y. (2019) · Clinica Chimica Acta · doi:10.1016/j.cca.2019.02.021 · Cited by 223 · cited 2×
“35 To guarantee very pure separation, the immuno-isolation method employs magnetic beads coated with antibodies to target proteins on the exosomes surface.”
BackgroundMethodCone, A. S., Yuan, X., Sun, L., Duke, L. C., Vreones, M. P., Carrier, A. N., Kenyon, S. M., Carver, S. R., Benthem, S. D., Stimmell, A. C., et al. (2021) · Theranostics · doi:10.7150/thno.62069 · Cited by 223
Circulating miRNAs as Potential Biomarkers in Alzheimer's Disease
Galimberti, D., Villa, C., Fenoglio, C., Serpente, M., Ghezzi, L., Cioffi, S. M. G., Arighi, A., Fumagalli, G., & Scarpini, E. (2014) · Journal of Alzheimer’s Disease · doi:10.3233/jad-140756 · Cited by 222
Circulating miR-125b as a biomarker of Alzheimer's disease
Tan, L., Yu, J.-T., Liu, Q.-Y., Tan, M.-S., Zhang, W., Hu, N., Wang, Y.-L., Sun, L., Jiang, T., & Tan, L. (2014) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2013.10.002 · Cited by 222
Endo-lysosomal dysregulations and late-onset Alzheimer’s disease: impact of genetic risk factors
Van Acker, Z. P., Bretou, M., & Annaert, W. (2019) · Molecular Neurodegeneration · doi:10.1186/s13024-019-0323-7 · Cited by 222
Role of Exosomes in Central Nervous System Diseases
Liu, W., Bai, X., Zhang, A., Huang, J., Xu, S., & Zhang, J. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00240 · Cited by 221 · cited 1×
“246 Numerous studies suggest that stem cell-derived exosomes may improve AD pathology.”
BackgroundNakano, M., Kubota, K., Kobayashi, E., Chikenji, T. S., Saito, Y., Konari, N., & Fujimiya, M. (2020) · Scientific Reports · doi:10.1038/s41598-020-67460-1 · Cited by 219
Tamboli, I. Y., Barth, E., Christian, L., Siepmann, M., Kumar, S., Singh, S., Tolksdorf, K., Heneka, M. T., Lütjohann, D., Wunderlich, P., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.149468 · Cited by 218
Exosomes as new diagnostic tools in CNS diseases
Kanninen, K. M., Bister, N., Koistinaho, J., & Malm, T. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.09.020 · Cited by 218 · cited 3×
“Exosome contents may vary under diverse stimuli and can be identified via proteomics, lipidomics, sequencing, and PCR. 12 Thorough investigation and comprehension of exosomes have improved the knowledge of their roles in three areas: 1) Exosomes carry unique contents that facilitate cell-cell…”
BackgroundInfluentialGenome-Wide Serum microRNA Expression Profiling Identifies Serum Biomarkers for Alzheimer's Disease
Tan, L., Yu, J.-T., Tan, M.-S., Liu, Q.-Y., Wang, H.-F., Zhang, W., Jiang, T., & Tan, L. (2014) · Journal of Alzheimer’s Disease · doi:10.3233/jad-132144 · Cited by 215
The Role of NLRP3 Inflammasome in Alzheimer’s Disease and Potential Therapeutic Targets
Liang, T., Zhang, Y., Wu, S., Chen, Q., & Wang, L. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.845185 · Cited by 213
Serum MicroRNA Profiles Serve as Novel Biomarkers for the Diagnosis of Alzheimer’s Disease
Dong, H., Li, J., Huang, L., Chen, X., Li, D., Wang, T., Hu, C., Xu, J., Zhang, C., Zen, K., et al. (2015) · Disease Markers · doi:10.1155/2015/625659 · Cited by 211 · cited 1×
“Using Solexa sequencing and qRT-PCR, Dong et al 158 identified blood exosome miRNAs such miR-31, miR-93, miR-143, and miR-146a for AD diagnosis.”
MethodSubtyping of circulating exosome-bound amyloid β reflects brain plaque deposition
Lim, C. Z. J., Zhang, Y., Chen, Y., Zhao, H., Stephenson, M. C., Ho, N. R. Y., Chen, Y., Chung, J., Reilhac, A., Loh, T. P., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09030-2 · Cited by 209 · cited 1×
“167 It has been postulated that proteins associated with neuroinflammation found in astrocyte and stem cell derived blood exosome extracts might serve as AD biomarkers.”
BackgroundInflammation context in Alzheimer’s disease, a relationship intricate to define
Novoa, C., Salazar, P., Cisternas, P., Gherardelli, C., Vera-Salazar, R., Zolezzi, J. M., & Inestrosa, N. C. (2022) · Biological Research · doi:10.1186/s40659-022-00404-3 · Cited by 206 · cited 1×
“94 Exosomes may contain harmful proteins like Aβ or tau, and activated glial or neuronal cells could release them into environment, exacerbating neuroinflammatory effects.”
BackgroundLi, J. J., Wang, B., Kodali, M. C., Chen, C., Kim, E., Patters, B. J., Lan, L., Kumar, S., Wang, X., Yue, J., et al. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-017-1038-8 · Cited by 204 · cited 1×
“Li et al 87 investigated the involvement of serum-derived exosomes in the process of neuroinflammation by utilizing the endotox-emia model with lipopolysaccharide (LPS).”
MethodXia, X., Wang, Y., Huang, Y., Zhang, H., Lu, H., & Zheng, J. C. (2019) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2019.101694 · Cited by 202
LIU, C.-G., SONG, J., ZHANG, Y.-Q., & WANG, P.-C. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2484 · Cited by 201 · cited 1×
“153 Another AD-related biomarker is blood or CSF exosomal miR-451a.”
BackgroundVingtdeux, V., Hamdane, M., Loyens, A., Gelé, P., Drobeck, H., Bégard, S., Galas, M.-C., Delacourte, A., Beauvillain, J.-C., Buée, L., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609475200 · Cited by 195 · cited 1×
“58 Exosomes may also house critical members of the secretase family, including β-site APP cleaving enzyme 1, presenilin 1, and disintegrin.”
BackgroundDe novo induction of amyloid-β deposition in vivo
Morales, R., Duran-Aniotz, C., Castilla, J., Estrada, L. D., & Soto, C. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.120 · Cited by 191
Exosomes neutralize synaptic-plasticity-disrupting activity of Aβ assemblies in vivo
An, K., Klyubin, I., Kim, Y., Jung, J. H., Mably, A. J., O’Dowd, S. T., Lynch, T., Kanmert, D., Lemere, C. A., Finan, G. M., et al. (2013) · Molecular Brain · doi:10.1186/1756-6606-6-47 · Cited by 185 · cited 1×
“135,164 In 2014, Yuyama et al found that exosomes scavenge Aβ via Aβ-glycan and exosome-glycosphingolipid attachment.”
BackgroundRole of Mitochondrial Amyloid-β in Alzheimer's Disease
Chen, J. X., & Yan, S. S. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-100357 · Cited by 183
Li, D., Zhang, P., Yao, X., Li, H., Shen, H., Li, X., Wu, J., & Lu, X. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00845 · Cited by 180 · cited 1×
“235,236 Because exosomes mediate the transfer of foreign substances and cargo, including proteins, mRNAs, miRNAs, and lipids, from one cell to another, the idea of using them to transport drugs has evolved from their function as a mediator of intercellular communication.”
BackgroundDiagnostic and therapeutic potential of exosomes in Alzheimer’s disease
Soares Martins, T., Trindade, D., Vaz, M., Campelo, I., Almeida, M., Trigo, G., da Cruz e Silva, O. A. B., & Henriques, A. G. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15112 · Cited by 174
BIN1 favors the spreading of Tau via extracellular vesicles
Crotti, A., Sait, H. R., McAvoy, K. M., Estrada, K., Ergun, A., Szak, S., Marsh, G., Jandreski, L., Peterson, M., Reynolds, T. L., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-45676-0 · Cited by 171
Yin, Z., Han, Z., Hu, T., Zhang, S., Ge, X., Huang, S., Wang, L., Yu, J., Li, W., Wang, Y., et al. (2020) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2019.11.004 · Cited by 171
Cosín‐Tomás, M., Antonell, A., Lladó, A., Alcolea, D. A., Fortea, J., Ezquerra, M., Lleó, A., Martí, M. J., Pallàs, M., Sánchez‐Valle, R., et al. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0088-8 · Cited by 169 · cited 1×
“[195] miR-34a, miR-146a Plasma Downregulated These miRNAs are downregulated in AD samples and show suitable diagnostic accuracy to distinguish AD patients from healthy controls.”
BackgroundMesenchymal stem cell-derived exosomal miR-223 regulates neuronal cell apoptosis
Wei, H., Xu, Y., Chen, Q., Chen, H., Zhu, X., & Li, Y. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2490-4 · Cited by 168
MicroRNA-455-3p as a potential peripheral biomarker for Alzheimer’s disease
Kumar, S., Vijayan, M., & Reddy, P. H. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx267 · Cited by 167
Gámez-Valero, A., Campdelacreu, J., Vilas, D., Ispierto, L., Reñé, R., Álvarez, R., Armengol, M. P., Borràs, F. E., & Beyer, K. (2019) · Translational Neurodegeneration · doi:10.1186/s40035-019-0169-5 · Cited by 167
Chen, Y.-A., Lu, C.-H., Ke, C.-C., Chiu, S.-J., Jeng, F.-S., Chang, C.-W., Yang, B.-H., & Liu, R.-S. (2021) · Biomedicines · doi:10.3390/biomedicines9060594 · Cited by 167 · cited 1×
“218 By correcting BDNF-associated neuropathology, bone-MSC exosomes slow cognitive decline in AD-like mice.”
BackgroundMcKeever, P. M., Schneider, R., Taghdiri, F., Weichert, A., Multani, N., Brown, R. A., Boxer, A. L., Karydas, A., Miller, B., Robertson, J., et al. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1032-x · Cited by 166
Falker, C., Hartmann, A., Guett, I., Dohler, F., Altmeppen, H., Betzel, C., Schubert, R., Thurm, D., Wegwitz, F., Joshi, P., et al. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13514 · Cited by 165 · cited 1×
“64 Results indicate that NDEs may capture Aβ via GSLs and PrP(C) in a single or synergistic way, promoting Aβ aggregation and amyloid plaque formation.”
BackgroundCaruso Bavisotto, C., Scalia, F., Marino Gammazza, A., Carlisi, D., Bucchieri, F., Conway de Macario, E., Macario, A. J. L., Cappello, F., & Campanella, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20020434 · Cited by 165 · cited 1×
“10 Exosomes, containing proteins, lipids, and nucleic acid molecules, are transported from donor cells to distant recipient cells through mechanisms like phagocytosis, pinocytosis, endocytosis, or plasma membrane fusion, containing specific cargoes.”
BackgroundExosomes in Alzheimer's disease
Malm, T., Loppi, S. H., & Kanninen, K. M. (2016) · Neurochemistry International · doi:10.1016/j.neuint.2016.04.011 · Cited by 163
Characterization of High-Affinity Binding between Gangliosides and Amyloid β-Protein
Ariga, T., Kobayashi, K., Hasegawa, A., Kiso, M., Ishida, H., & Miyatake, T. (2001) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2001.2304 · Cited by 158 · cited 1×
“62,63 Especially NDE exosomes enrich GSLs. Exosomes may serve seeds for Aβ aggregation, and plaque development.”
BackgroundReduced expression of hsa-miR-27a-3p in CSF of patients with Alzheimer disease
Sala Frigerio, C., Lau, P., Salta, E., Tournoy, J., Bossers, K., Vandenberghe, R., Wallin, A., Bjerke, M., Zetterberg, H., Blennow, K., et al. (2013) · Neurology · doi:10.1212/01.wnl.0000437306.37850.22 · Cited by 156
Alifragis, P., & Marsh, J. (2018) · Neural Regeneration Research · doi:10.4103/1673-5374.230276 · Cited by 153 · cited 1×
“81,82 A study found that EV produced by Aβ1−42 activates microglia, which in turn causes a significant reduction in the density of dendritic spines in hippocampal neurons both in living organisms and in laboratory settings.”
BackgroundP2RX7 inhibitor suppresses exosome secretion and disease phenotype in P301S tau transgenic mice
Ruan, Z., Delpech, J.-C., Venkatesan Kalavai, S., Van Enoo, A. A., Hu, J., Ikezu, S., & Ikezu, T. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00396-2 · Cited by 150 · cited 1×
“141 Potentially new avenues for enhancing tau pathology include inhibiting P2RX7 to decrease exosome expression.”
BackgroundBulloj, A., Leal, M. C., Xu, H., Castaño, E. M., & Morelli, L. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-1206 · Cited by 149 · cited 2×
“New evidence from the following studies supports the idea that exosomes’ protective impact is directly related to IDE. 52,55 Released into the extracellular environment by exosomes, metalloproteases endothelin-converting enzyme (ECE)-1 and −2 may facilitate the breakdown of Aβ.”
BackgroundIncreased microRNA-34c abundance in Alzheimer's disease circulating blood plasma
Bhatnagar, S., Chertkow, H., Schipper, H. M., Yuan, Z., Shetty, V., Jenkins, S., Jones, T., & Wang, E. (2014) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2014.00002 · Cited by 148 · cited 1×
“[193] miR-92a-3p, miR-181c-5p, and miR-210-3p Plasma Upregulated The levels of these miRNAs are increased in the plasma of AD patients and can distinguish AD individuals from healthy controls.”
BackgroundLee, M., Ban, J.-J., Yang, S., Im, W., & Kim, M. (2018) · Brain Research · doi:10.1016/j.brainres.2018.03.034 · Cited by 147 · cited 1×
“215 Mesenchymal stromal cells (MSCs) have a high in-vitro multiplicity, are abundant in many tissues, and are easy to separate, making them a promising potential source of exosomes.”
BackgroundMicroRNA-29a Is a Candidate Biomarker for Alzheimer’s Disease in Cell-Free Cerebrospinal Fluid
Müller, M., Jäkel, L., Bruinsma, I. B., Claassen, J. A., Kuiperij, H. B., & Verbeek, M. M. (2016) · Molecular Neurobiology · doi:10.1007/s12035-015-9156-8 · Cited by 146
Nagaraj, S., Laskowska-Kaszub, K., Dębski, K. J., Wojsiat, J., Dąbrowski, M., Gabryelewicz, T., Kuźnicki, J., & Wojda, U. (2017) · Oncotarget · doi:10.18632/oncotarget.15109 · Cited by 146 · cited 1×
“[198] miR-30b-5p, miR-142-3p Downregulated miR-1908 Plasma Upregulated The level of this miRNA is increased in the plasma of AD patients and can distinguish AD patients from healthy controls.”
BackgroundThe Role of Exosomal microRNAs and Oxidative Stress in Neurodegenerative Diseases
Wang, X., Zhou, Y., Gao, Q., Ping, D., Wang, Y., Wu, W., Lin, X., Fang, Y., Zhang, J., & Shao, A. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/3232869 · Cited by 144 · cited 1×
“102 Furthermore, intracellular amyloid-β accumulation triggers oxidative and inflammatory pathways, creating a loop of oxidation and amyloid-β production.”
BackgroundEmergence of exosomal miRNAs as a diagnostic biomarker for Alzheimer's disease
Giau, V. V., & An, S. S. A. (2015) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2015.12.005 · Cited by 143
Serum microRNA miR-501-3p as a potential biomarker related to the progression of Alzheimer’s disease
Hara, N., Kikuchi, M., Miyashita, A., Hatsuta, H., Saito, Y., Kasuga, K., Murayama, S., Ikeuchi, T., & Kuwano, R. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0414-z · Cited by 142
Neurovascular Defects and Faulty Amyloid-β Vascular Clearance in Alzheimer's Disease
Sagare, A. P., Bell, R. D., & Zlokovic, B. V. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-129037 · Cited by 140 · cited 1×
“127 Using DNA sequencing and proteomics to analyze gene expression levels supports the Aβ-inflammation-angiogenesis theory in AD.”
MethodElia, C. A., Tamborini, M., Rasile, M., Desiato, G., Marchetti, S., Swuec, P., Mazzitelli, S., Clemente, F., Anselmo, A., Matteoli, M., et al. (2019) · Cells · doi:10.3390/cells8091059 · Cited by 139
The emerging role of exosomes in Alzheimer’s disease
Zhang, T., Ma, S., Lv, J., Wang, X., Afewerky, H. K., Li, H., & Lu, Y. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101321 · Cited by 139 · cited 1×
“11 Additionally, exosomes are seen as carrier vehicles that may travel actively between cells, facilitating material and information exchange.”
BackgroundAstrocyte and Alzheimer’s disease
Cai, Z., Wan, C., & Liu, Z. (2017) · Journal of Neurology · doi:10.1007/s00415-017-8593-x · Cited by 135 · cited 1×
“104 Oxidative stress triggers Aβ formation via p38 mitogen-stimulated protein kinase signaling, NFκB binding, or lipid peroxidation.”
BackgroundMicroRNAs in Human Cerebrospinal Fluid as Biomarkers for Alzheimer’s Disease
Lusardi, T. A., Phillips, J. I., Wiedrick, J. T., Harrington, C. A., Lind, B., Lapidus, J. A., Quinn, J. F., & Saugstad, J. A. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-160835 · Cited by 132
Treatment Options in Alzheimer’s Disease: Maximizing Benefit, Managing Expectations
Farlow, M. R., Miller, M. L., & Pejovic, V. (2008) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000122962 · Cited by 129
Wang, S.-S., Jia, J., & Wang, Z. (2018) · Journal of Alzheimer’s Disease · doi:10.3233/jad-170848 · Cited by 127
Trem2 deletion enhances tau dispersion and pathology through microglia exosomes
Zhu, B., Liu, Y., Hwang, S., Archuleta, K., Huang, H., Campos, A., Murad, R., Piña-Crespo, J., Xu, H., & Huang, T. Y. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00562-8 · Cited by 127 · cited 3×
“Zhu et al 92 found that deleting the Trem2 gene in mice (Trem2 KO) can increase the spread of tau protein from the medial entorhinal cortex (MEC) to the hippocampus.”
BackgroundInfluentialBiasutto, L., Chiechi, A., Couch, R., Liotta, L. A., & Espina, V. (2013) · Experimental Cell Research · doi:10.1016/j.yexcr.2013.05.005 · Cited by 126 · cited 1×
“113 Oxidative stress has been found to change the lipid content of exosomes, specifically affecting the amounts of oxidized lipids, and their transfer across cells.”
BackgroundRedox-dependent thiol modifications: implications for the release of extracellular vesicles
Benedikter, B. J., Weseler, A. R., Wouters, E. F. �., Savelkoul, P. H. M., Rohde, G. G. U., & Stassen, F. R. M. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2806-z · Cited by 124
Derkow, K., Rössling, R., Schipke, C., Krüger, C., Bauer, J., Fähling, M., Stroux, A., Schott, E., Ruprecht, K., Peters, O., et al. (2018) · PLOS ONE · doi:10.1371/journal.pone.0200602 · Cited by 122
Siedlecki-Wullich, D., Català-Solsona, J., Fábregas, C., Hernández, I., Clarimon, J., Lleó, A., Boada, M., Saura, C. A., Rodríguez-Álvarez, J., & Miñano-Molina, A. J. (2019) · Alzheimer's Research & Therapy · doi:10.1186/s13195-019-0501-4 · Cited by 118 · cited 1×
“[194] miR-34a-5p and miR-545-3p Plasma Downregulated These miRNAs are downregulated in AD samples and show suitable diagnostic accuracy to distinguish AD patients from healthy controls.”
BackgroundWinston, C. N., Goetzl, E. J., Schwartz, J. B., Elahi, F. M., & Rissman, R. A. (2019) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1016/j.dadm.2018.11.002 · Cited by 118 · cited 1×
“80,170 There is an association between elevated levels of GABARAP, prion proteins (PrP), and APP with the presence of damaged mitochondrial organelles in extracellular vesicles (EV) isolated from the brains of preclinical AD patients.”
BackgroundLópez‐Ortiz, S., Pinto-Fraga, J., Valenzuela, P. L., Martín-Hernández, J., Seisdedos, M. M., García, Ó., Toschi, N., Giuliano, F. D., Garaci, F. G., Mercuri, N. B., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22062897 · Cited by 115 · cited 1×
“122 Angiogenesis, the formation of new blood vessels from pre-existing vessels, is a complex and coordinated process that involves vascular degradation.”
BackgroundExosomes as Carriers of Alzheimer's Amyloid-ß
Yuyama, K., & Igarashi, Y. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00229 · Cited by 114 · cited 1×
“235,236 Because exosomes mediate the transfer of foreign substances and cargo, including proteins, mRNAs, miRNAs, and lipids, from one cell to another, the idea of using them to transport drugs has evolved from their function as a mediator of intercellular communication.”
BackgroundGhidoni, R., Paterlini, A., Albertini, V., Glionna, M., Monti, E., Schiaffonati, L., Benussi, L., Levy, E., & Binetti, G. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.08.013 · Cited by 111 · cited 1×
“Exosomes include proteins with several powerful protective roles for neurons, such as Cystatin C. 133,134 Neprilysin (NEP) and insulin-degrading enzyme (IDE), two enzymes involved in the breakdown of Aβ, are also found in exosomes.”
BackgroundManček‐Keber, M., Frank‐Bertoncelj, M., Hafner‐Bratkovič, I., Smole, A., Zorko, M. S., Pirher, N., Hayer, S., Kralj‐Iglič, V., Rozman, B., Ilc, N., et al. (2015) · Science Signaling · doi:10.1126/scisignal.2005860 · Cited by 110 · cited 1×
“114 Establishing a two-way connection is essential for preserving cellular balance in the face of oxidative stress.”
BackgroundNeuroinflammation: A Modifiable Pathway Linking Obesity, Alzheimer's disease, and Depression
Ly, M., Yu, G. Z., Mian, A., Cramer, A., Meysami, S., Merrill, D. A., Samara, A., Eisenstein, S. A., Hershey, T., Babulal, G. M., et al. (2023) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2023.06.001 · Cited by 108
LIU, C.-G., WANG, J.-L., LI, L., & WANG, P.-C. (2014) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2014.1780 · Cited by 106 · cited 1×
“[197] miR-483-5p, miR-486-5p, miR-200a-3p, miR502-3p Plasma Upregulated These miRNAs can distinguish AD patients from healthy controls.”
BackgroundKhan, A., Vaibhav, K., Javed, H., Khan, M. M., Tabassum, R., Ahmed, M. E., Srivastava, P., Khuwaja, G., Islam, F., Siddiqui, M. S., et al. (2012) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-012-1368-x · Cited by 106 · cited 1×
“106 Studies indicate that monomeric units and micro-oligomers Aβ are responsible for generating oxidative stress, which results in cell damage and neuronal death, rather than plaques.”
BackgroundWinston, C. N., Romero, H. K., Ellisman, M., Nauss, S., Julovich, D. A., Conger, T., Hall, J. R., Campana, W., O’Bryant, S. E., Nievergelt, C. M., et al. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01005 · Cited by 105
Brain Derived Exosomes Are a Double-Edged Sword in Alzheimer’s Disease
Song, Z., Xu, Y., Deng, W., Zhang, L., Zhu, H., Yu, P., Qu, Y., Zhao, W., Han, Y., & Qin, C. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.00079 · Cited by 104 · cited 1×
“41 Exosomes have comparable cargoes, but also exhibit cell specificity determined by the chemicals in their source cells and the physiological or pathological circumstances during exosome synthesis.”
BackgroundLower Serum Levels of miR-29c-3p and miR-19b-3p as Biomarkers for Alzheimer’s Disease
Wu, Y., Xu, J., Xu, J., Cheng, J., Jiao, D., Zhou, C., Dai, Y., & Chen, Q. (2017) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.242.129 · Cited by 103
Giovannelli, L., Bari, E., Jommi, C., Tartara, F., Armocida, D., Garbossa, D., Cofano, F., Torre, M. L., & Segale, L. (2023) · Bioactive Materials · doi:10.1016/j.bioactmat.2023.06.013 · Cited by 102 · cited 1×
“168,169 Evidence suggests that these cells secreted exosomes from AD patients include much greater quantities of pro-inflammatory factors and complement factors.”
BackgroundDong, Z., Gu, H., Guo, Q., Liang, S., Xue, J., Yao, F., Liu, X., Li, F., Liu, H., Sun, L., et al. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02323-y · Cited by 101 · cited 1×
“[202] miR-30b-5p Downregulated miR-342-5p Serum (Exosome) Downregulated The level of this miRNA is downregulated in the plasma of AD patients and can distinguish AD patients from healthy controls.”
BackgroundTau Overexpression Results in Its Secretion via Membrane Vesicles
Simón, D., García-García, E., Gómez-Ramos, A., Falcón-Pérez, J. M., Díaz-Hernández, M., Hernández, F., & Avila, J. (2012) · Neurodegenerative Diseases · doi:10.1159/000334915 · Cited by 100
Ahmed, N. E.-M. B., Murakami, M., Hirose, Y., & Nakashima, M. (2016) · Stem Cells International · doi:10.1155/2016/8102478 · Cited by 99 · cited 2×
“Recent scientific discoveries have shown that exosomes derived from dental pulp stem cells (DPSCs), 216 bone marrow stromal cells (BMSCs), 217,240 and adipose-derived stem cells (ADSCs) contain neprilysin and an insulin-degrading enzyme, the roles of which are to break down Aβ.”
BackgroundMethodBaker, S., Polanco, J. C., & Götz, J. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-160371 · Cited by 98
Downregulated serum miR‐223 servers as biomarker in Alzheimer's disease
Jia, L., & Liu, Y. (2016) · Cell Biochemistry and Function · doi:10.1002/cbf.3184 · Cited by 95
Negri, L., & Ferrara, N. (2018) · Physiological Reviews · doi:10.1152/physrev.00012.2017 · Cited by 93
Exosomes and microRNAs: New potential therapeutic candidates in Alzheimer disease therapy
Iranifar, E., Seresht, B. M., Momeni, F., Fadaei, E., Mehr, M. H., Ebrahimi, Z., Rahmati, M., Kharazinejad, E., & Mirzaei, H. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.27214 · Cited by 93
Nie, C., Sun, Y., Zhen, H., Guo, M., Ye, J., Liu, Z., Yang, Y., & Zhang, X. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00438 · Cited by 89
Peterson, A. R., & Binder, D. K. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00164 · Cited by 87 · cited 1×
“241,242 Toxic Waste Scavenging and Neuroprotective Effects Exosomes have the ability to attach to Aβ via glycosphingolipids on the surface of the cell membrane, making them excellent Aβ scavengers.”
BackgroundTetraspanins: Architects of Viral Entry and Exit Platforms
Hantak, M. P., Qing, E., Earnest, J. T., & Gallagher, T. (2019) · Journal of Virology · doi:10.1128/jvi.01429-17 · Cited by 86 · cited 1×
“234 Moreover, exosomes have the ability to enter tissues, spread throughout the circulation, and traverse the blood-brain barrier (BBB) in a specific way, which makes them ideal vectors for delivering genetic and medicinal components to treat neurological diseases.”
BackgroundYarana, C., & Clair, D. K. S. (2017) · Antioxidants · doi:10.3390/antiox6040075 · Cited by 83
Wang, X., & Yang, G. (2021) · Cell Biology International · doi:10.1002/cbin.11522 · Cited by 83 · cited 1×
“225 Many inflammation-related disorders may be treated using hucMSC exosomes.”
BackgroundPeng, H., Liang, Z., Piao, H. Z., Ji, X., Wang, Y., Liu, Y., Liu, R., & Liu, J. (2014) · Metabolic Brain Disease · doi:10.1007/s11011-014-9490-y · Cited by 81 · cited 1×
“243 There is evidence that changes in NF-κB are associated with cancer, inflammatory and autoimmune disorders, septic shock, viral infections, and the development of synaptic plasticity and memory.”
BackgroundSoliman, H. M., Ghonaim, G. A., Gharib, S. M., Chopra, H., Farag, A. K., Hassanin, M. H., Nagah, A., Emad-Eldin, M., Hashem, N. E., Yahya, G., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910794 · Cited by 81 · cited 1×
“13 Exosomes associated with AD were first discovered while studying the buildup of APP cleavage in MVBs, 14,15 which are considered as progenitors of exosomes.”
BackgroundYılmaz, Ş. G., Erdal, M. E., Özge, A. A., & Sungur, M. A. (2016) · OMICS: A Journal of Integrative Biology · doi:10.1089/omi.2016.0099 · Cited by 77
Targetting Exosomes as a New Biomarker and Therapeutic Approach for Alzheimer’s Disease
Yin, Q., Ji, X., Lv, R., Pei, J.-J., Du, Y., Shen, C., & Hou, X. (2020) · Clinical Interventions in Aging · doi:10.2147/cia.s240400 · Cited by 77
Katsuda, T., Oki, K., & Ochiya, T. (2014) · Methods in molecular biology · doi:10.1007/7651_2014_98 · Cited by 76 · cited 2×
“216,217 In AD, stem cells and other cell-derived or bioengineered exosomes are useful.”
BackgroundMilk exosomes: A biogenic nanocarrier for small molecules and macromolecules to combat cancer
Kandimalla, R., Aqil, F., Tyagi, N., & Gupta, R. C. (2020) · American Journal of Reproductive Immunology · doi:10.1111/aji.13349 · Cited by 74
Gallart-Palau, X., Guo, X., Serra, A., & Sze, S. K. (2020) · Alzheimer's Research & Therapy · doi:10.1186/s13195-020-00623-4 · Cited by 73 · cited 1×
“171 –174 Taken together, the aforementioned research provide credence to the idea that exosomes might be useful as biomarkers for AD (Table 1).”
BackgroundVEGFR1 and VEGFR2 in Alzheimer’s Disease
Harris, R., Miners, J. S., Allen, S. J., & Love, S. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170745 · Cited by 72
Association of Aβ with ceramide-enriched astrosomes mediates Aβ neurotoxicity
Elsherbini, A., Kirov, A. S., Dinkins, M. B., Wang, G., Qin, H., Zhu, Z., Tripathi, P., Crivelli, S. M., & Bieberich, E. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-00931-8 · Cited by 72 · cited 1×
“85,86 Interestingly, peripheral exosomal contents may potentiate CNS inflammation, which may play a part in explaining how a peripheral pro-inflammatory state such as depression, obesity, diabetes can be risk factors for AD.”
BackgroundKenny, A., McArdle, H., Calero, M., Rabano, A., Madden, S. F., Adamson, K., Forster, R., Spain, E., Prehn, J. H. M., Henshall, D. C., et al. (2019) · SSRN Electronic Journal · doi:10.2139/ssrn.3429882 · Cited by 71 · cited 1×
“[200] miR-103, miR-107 Plasma Downregulated The level of these miRNAs are downregulated in the plasma of AD patients and can distinguish AD patients from healthy controls.”
BackgroundMolecular and genetic inflammation networks in major human diseases
Zhao, Y., Forst, C. V., Sayegh, C. E., Wang, I.-M., Yang, X., & Zhang, B. (2016) · Molecular BioSystems · doi:10.1039/c6mb00240d · Cited by 69 · cited 1×
“128 Interestingly, several genetic factor translation products promote angiogenesis.”
BackgroundExosomal miRNAs as Potential Diagnostic Biomarkers in Alzheimer’s Disease
Manna, I., De Benedittis, S., Quattrone, A., Maisano, D., Iaccino, E., & Quattrone, A. (2020) · Pharmaceuticals · doi:10.3390/ph13090243 · Cited by 68
TREM2 Ameliorates Neuronal Tau Pathology Through Suppression of Microglial Inflammatory Response
Jiang, T., Zhang, Y., Gao, Q., Ou, Z., Gong, P., Shi, J., Wu, L., & Zhou, J. (2018) · Inflammation · doi:10.1007/s10753-018-0735-5 · Cited by 66 · cited 1×
“140 These findings lend credence to the idea that TREM2 may prevent tau pathogenesis by way of microglia exosomes.”
BackgroundExosomes: a novel therapeutic target for Alzheimer’s disease?
Cai, Z.-Y., Ke, Z.-Y., Xiao, M., & Quazi, S. (2018) · Neural Regeneration Research · doi:10.4103/1673-5374.232490 · Cited by 64 · cited 2×
“75 Exosomes play a large role in neuroinflammation as a natural nanocarrier of harmful inflammatory chemicals.”
BackgroundMiyoshi, E., Bilousova, T., Melnik, M., Fakhrutdinov, D., Poon, W. W., Vinters, H. V., Miller, C. A., Corrada, M., Kawas, C., Bohannan, R., et al. (2021) · Laboratory Investigation · doi:10.1038/s41374-021-00644-z · Cited by 64
Wang, J., Chen, C., & Zhang, Y. (2020) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.23006 · Cited by 62
Shigemizu, D., Akiyama, S., Asanomi, Y., Boroevich, K. A., Sharma, A., Tsunoda, T., Matsukuma, K., Ichikawa, M., Sudo, H., Takizawa, S., et al. (2019) · Communications Biology · doi:10.1038/s42003-019-0324-7 · Cited by 61
Extracellular vesicles as an emerging tool for the early detection of Alzheimer’s disease
Li, T.-R., Wang, X.-N., Sheng, C., Li, Y.-X., Li, F. Z.-T., Sun, Y., & Han, Y. (2019) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2019.111175 · Cited by 60
Cited by
Serrano, D. R., Juste, F., Anaya, B. J., Ramirez, B. I., Sánchez-Guirales, S. A., Moyota, J. M. Q., Hernandez, E. M., Simon, J. A., Trallero, J. M., Serrano, C., et al. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17101336 · Cited by 143
“Neurogenetic Disorders: Exosome-based strategies delivering CRISPR/Cas9, mRNA, or RNAi have been tested in mouse models of Huntington’s disease and Amyotrophic Lateral Sclerosis, enabling gene modulation within the brain and prolonging survival in early studies [82].”
Kochman, U., Sitka, H., Kuźniar, J., Czaja, M., Kozubek, P., Beszłej, J. A., & Leszek, J. (2026) · Molecular Neurobiology · doi:10.1007/s12035-025-05417-z · Cited by 60
The role of exosomes in diagnosis, pathophysiology, and management of Alzheimer's Disease
Daksh, R., Mathew, M. S., Bosco, A. M., Sojan, C., Tom, A. A., Bojja, S. L., & Nampoothiri, M. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.151526 · Cited by 18
Shahlaei, M., Afkhami, H., Ahmadieh-Yazdi, A., Mirmazloumi, S. H., Sahraei, S. S., Akbari, M., Yang, P., Manoochehri, H., Tanzadehpanah, H., Mahaki, H., et al. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118548 · Cited by 22
An Update of Salivary Biomarkers for the Diagnosis of Alzheimer’s Disease
Guo, H., RuiHuan, Y., Cheng, W., Li, Q., & Du, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26052059 · Cited by 17
“Exosomes are vehicles for proteins, DNA, mRNA, miRNA, and other non-coding RNAs (ncRNAs) and are involved in A β -amyloid deposits, the formation of NFTs, neuroinflammation, and neuronal dysfunction in AD [95,96].”
Metadata
- Authors
- Sun, M., & Chen, Z.
- Affiliations
- Changzhou No.2 People's Hospital (CN)
- Corresponding author
- Sun, Mingyue
- Chen, Zhuoyou
- Venue
- Journal of Inflammation Research
- Publisher
- Informa UK Limited
- Published
- 2024-06
- Volume
- Volume 17
- Pages
- 3921-3948
- ISSN
- 1178-7031 (ISSN-L)
- PMC
- PMC11193473
- OpenAlex
- W4399787176
- Cited by
- 39
- References
- 249
- Citations by year
- 2026: 17 · 2025: 21 · 2024: 1
- FWCI
- 1.59
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Inflammation Research (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- exosomes, Alzheimer's disease, extracellular vesicles, amyloid-beta, tau hyperphosphorylation, neurofibrillary tangles, exosome biogenesis, intercellular communication, neurodegeneration, early detection, therapeutic target
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.